VERA - Vera Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VERA is currently covered by 6 analysts with an average price target of $75.66. This is a potential upside of $25.86 (51.93%) from yesterday's end of day stock price of $49.8.

Vera Therapeutics's activity chart (see below) currently has 67 price targets and 54 ratings on display. The stock rating distribution of VERA is 81.82% BUY and 18.18% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.57% with an average time for these price targets to be met of 123.44 days.

Highest price target for VERA is $100, Lowest price target is $23, average price target is $60.2.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 07-Nov-2025. First documented stock forecast 08-Jun-2021.

Currently out of the existing stock ratings of VERA, 9 are a BUY (81.82%), 2 are a HOLD (18.18%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$52

$18.25 (54.07%)

$68

1 months 6 days ago
(07-Nov-2025)

5/13 (38.46%)

$26.78 (106.19%)

271

Hold

$23

$-10.75 (-31.85%)

$26

6 months 4 days ago
(09-Jun-2025)

9/9 (100%)

$0.81 (3.65%)

152

Buy

$65

$31.25 (92.59%)

$60

6 months 11 days ago
(02-Jun-2025)

0/2 (0%)

$33.26 (104.79%)

Buy

$100

$66.25 (196.30%)

$107

7 months 6 days ago
(07-May-2025)

0/5 (0%)

$77.38 (342.09%)

Buy

$61

$27.25 (80.74%)

$64

9 months 16 days ago
(27-Feb-2025)

1/5 (20%)

$31.59 (107.41%)

163

Show more analysts

Please expand the browser size to see the chart

What is VERA (Vera Therapeutics) average time for price targets to be met?

On average it took 123.44 days on average for the stock forecasts to be realized with a an average price target met ratio 55.57

Which analyst has the current highest performing score on VERA (Vera Therapeutics) with a proven track record?

LIISA BAYKO

Which analyst has the current lower performing score on VERA (Vera Therapeutics) with a proven track record?

GREG HARRISON

Which analyst has the most public recommendations on VERA (Vera Therapeutics)?

Liisa Bayko works at EVERCORE and has 14 price targets and 10 ratings on VERA

Which analyst is the currently most bullish on VERA (Vera Therapeutics)?

Pete Stavropoulos with highest potential upside - $66.25

Which analyst is the currently most reserved on VERA (Vera Therapeutics)?

Maury Raycroft with lowest potential downside - -$27.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?